Research on magnesium specifically for anxiety relief is not well supported by the studies provided here. The available evidence consists of a prospective observational study examining intravenous magnesium sulfate combined with ketamine for chronic pain — in which anxiety reduction appeared as a secondary finding rather than a primary outcome — and a qualitative study on Long Covid patient experiences that does not address magnesium at all. Studies indicate that any signal of anxiety benefit in the observational study should be interpreted cautiously, given the absence of a control group, the combination treatment design, and the fact that anxiety was not the focus of the research. Overall, these two studies do not constitute a meaningful evidence base for drawing conclusions about magnesium as an intervention for anxiety, and readers seeking research on this topic should look to dedicated randomized controlled trials or systematic reviews.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Effectiveness of continuous Ketamine infusion associated with magnesium sulfa... | Other | 2025 | Mixed | 90 |
| Exploring the help-seeking journeys for Long Covid from a health inequalities... | Other | 2024 | Neutral | 85 |